In its simplest form at CliniSys, it is about ‘joining the dots’ and bringing the organisation together as one powerful brand and voice. Marketing planning is already underway and starting in the first quarter of 2021 there will be a series of initiatives to support the CliniSys Group’s marketing and corporate goals.
Embracing digital pathology, future-oriented pathology lab reaches beyond its hospital walls.
“Customers don’t know what they don’t know” – day to day usage is one thing but learning about additional or newly developed functionality to speed up workflow and provide other benefits is essential.
Effectively triaging ICT issues as soon as they arise is crucial for fixing them says Felice Di Rienzo, Services Director at CliniSys. The triage process involves critically analysing a pathology system to identify the component in the puzzle that’s failing. The quicker this can happen, the faster it can be resolved.
One of the major drivers for forming genomic laboratory hubs is to ensure quality at scale and equitable testing, by encouraging greater standardisation. However, CliniSys genomics consultant Steve Abbs argues that hubs in themselves will struggle to achieve this, and other drivers and facilitators are needed – not least a single LIMS.
If you are about to embark on going out to tender to find a CellPath LIMS supplier, what are the criteria you should consider in choosing a vendor? Sam Grobler, CliniSys product manager, offers some key recommendations.
